P&G financials
This article was originally published in The Tan Sheet
Executive Summary
Health Care sales advanced 18% to $1.4 bil. in third quarter (ended March 31), fueled by continued strength in oral care business, consumer products firm announces in April 28 1financial release. Price adjustments aimed at positioning Crest Whitestrips more competitively against Colgate Simply White offset a 3% positive currency impact during the period. P&G delayed launch of companion Whitestrips product, Crest Night Effects, from March until end of April because production could not meet retailer demand, firm says. Health Care earnings increased 19% to $147 mil. in Q3...